LivaNova (LIVN) Total Debt Growth (1y) (2016 - 2026)
LivaNova (LIVN) Total Debt Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.85 Bn | 194.25 Bn | 7.27 Bn | 142.67% |
| 2 | Stryker | 129.75 Bn | 126.28 Bn | 4.50 Bn | -9.88% |
| 3 | Medtronic | 119.86 Bn | 110.64 Bn | 6.41 Bn | -1.95% |
| 4 | Boston Scientific | 74.04 Bn | 73.50 Bn | 3.85 Bn | 1,188.16% |
| 5 | Edwards Lifesciences | 52.51 Bn | 48.26 Bn | 1.35 Bn | 0.12% |
| 6 | Dexcom | 34.75 Bn | 32.81 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.16 Bn | 32.05 Bn | 2.18 Bn | -17.79% |
| 8 | Koninklijke Philips | 26.43 Bn | 23.11 Bn | 4.55 Bn | -9.03% |
| 9 | Steris | 23.26 Bn | 22.78 Bn | 684.20 Mn | -0.50% |
| 10 | LivaNova | 4.32 Bn | 3.81 Bn | 273.67 Mn | -42.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -42.72% |
| Mar 31, 2026 | -59.32% |
| Dec 31, 2025 | -39.56% |
| Sep 30, 2025 | -30.62% |
| Jun 30, 2025 | -31.12% |
| Mar 31, 2025 | 13.33% |
| Dec 31, 2024 | 16.70% |
| Sep 30, 2024 | 6.65% |
| Jun 30, 2024 | 3.25% |
| Mar 31, 2024 | 10.71% |
| Dec 31, 2023 | 11.56% |
| Sep 30, 2023 | 5.10% |
| Jun 30, 2023 | 29.92% |
| Mar 31, 2023 | 22.01% |
| Dec 31, 2022 | 16.09% |
| Sep 30, 2022 | 20.88% |
| Jun 30, 2022 | -29.71% |
| Mar 31, 2022 | -29.76% |
| Dec 31, 2021 | -29.75% |
| Sep 30, 2021 | -29.01% |